Enzo Biochem INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
Enzo Biochem Inc. has completed its merger, resulting in reporting persons Bradley L. Radoff and Radoff Family Foundation no longer holding any securities.
Battery Ventures affiliates have filed a Schedule 13D, disclosing beneficial ownership of 21.8% of Enzo Biochem, Inc. common stock through voting agreements supporting a merger with Bethpage Parent, Inc.
Harbert Discovery Fund and its affiliates have entered into a voting and support agreement to back the all-equity merger of Enzo Biochem Inc. with Bethpage Parent, Inc.
Bradley L. Radoff, a significant shareholder and director of Enzo Biochem Inc., has formally agreed to support the company's merger with Bethpage Parent, Inc. by committing his substantial shareholdings.